학술논문
THU-116 - The ALBI grade refines prognostic prediction in advanced hepatocellular cancer and enables risk stratification for bleeding events following atezolizumab plus bevacizumab
Document Type
Abstract
Author
D’Alessio, Antonio; Fulgenzi, Claudia; Scheiner, Bernhard; Korolewicz, James; Cheon, Jaekyung; Nishida, Naoshi; Ang, Celina; Marron, Thomas; Wu, Linda; Saeed, Anwaar; Wietharn, Brooke; Cammarota, Antonella; Pressiani, Tiziana; Pinter, Matthias; Balcar, Lorenz; Huang, Yi-Hsiang; Mehan, Aman; Phen, Samuel; Vivaldi, Caterina; Salani, Francesca; Masi, Gianluca; Bettinger, Dominik; Vogel, Arndt; Schoenlein, Martin; von Felden, Johann; Schulze, Kornelius; Wege, Henning; Samson, Adel; Galle, Peter; Kudo, Masatoshi; Cortellini, Alessio; Singal, Amit; Rimassa, Lorenza; Sharma, Rohini; Chon, Hong Jae; Pinato, David J.
Source
In Journal of Hepatology June 2023 78 Supplement 1:S575-S575
Subject
Language
ISSN
0168-8278